
Inhalable mRNA with Ethris' Carsten Rudolph, Ph.D.
Business Of Biotech
Development of Inhalable mRNA for Gene Therapy
This chapter explores the speaker's background in mRNA research, focusing on their work in developing gene therapy for cystic fibrosis. They discuss the challenges of delivering genes to lung tissue and their use of modified messenger RNA to reduce immune recognition. The chapter also discusses the early stages of forming a biotech company and their journey to secure investments.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.